| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
|
Blasco-Benito, Sandra
|
|
2018
|
157 |
C |
p. 285-293
|
article
|
| 2 |
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
|
Navarro, Gemma
|
|
2018
|
157 |
C |
p. 148-158
|
article
|
| 3 |
Cannabinoid pharmacology and therapy in gut disorders
|
Uranga, J.A.
|
|
2018
|
157 |
C |
p. 134-147
|
article
|
| 4 |
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
|
Aymerich, Maria S.
|
|
2018
|
157 |
C |
p. 67-84
|
article
|
| 5 |
Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders
|
Sagredo, Onintza
|
|
2018
|
157 |
C |
p. 85-96
|
article
|
| 6 |
Chronic pain and cannabinoids. Great expectations or a christmas carol
|
Pascual, D.
|
|
2018
|
157 |
C |
p. 33-42
|
article
|
| 7 |
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
|
Manterola, Andrea
|
|
2018
|
157 |
C |
p. 189-201
|
article
|
| 8 |
Editorial Board
|
|
|
2018
|
157 |
C |
p. ii
|
article
|
| 9 |
Effect of chronic THC administration in the reproductive organs of male mice, spermatozoa and in vitro fertilization
|
López-Cardona, A.P.
|
|
2018
|
157 |
C |
p. 294-303
|
article
|
| 10 |
EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis
|
García-Martín, Adela
|
|
2018
|
157 |
C |
p. 304-313
|
article
|
| 11 |
Emerging strategies targeting CB2 cannabinoid receptor: Biased agonism and allosterism
|
Morales, Paula
|
|
2018
|
157 |
C |
p. 8-17
|
article
|
| 12 |
Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model
|
Aso, Ester
|
|
2018
|
157 |
C |
p. 210-216
|
article
|
| 13 |
Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis
|
Mestre, L.
|
|
2018
|
157 |
C |
p. 51-66
|
article
|
| 14 |
Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases
|
Reyes-Resina, Irene
|
|
2018
|
157 |
C |
p. 169-179
|
article
|
| 15 |
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
|
Gil-Ordóñez, Ana
|
|
2018
|
157 |
C |
p. 18-32
|
article
|
| 16 |
Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis
|
Rodríguez-Cueto, Carmen
|
|
2018
|
157 |
C |
p. 217-226
|
article
|
| 17 |
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma
|
López-Valero, Israel
|
|
2018
|
157 |
C |
p. 275-284
|
article
|
| 18 |
Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure
|
Rivera, Patricia
|
|
2018
|
157 |
C |
p. 244-257
|
article
|
| 19 |
Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol
|
Navarrete, Francisco
|
|
2018
|
157 |
C |
p. 227-234
|
article
|
| 20 |
PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models
|
Alen, Francisco
|
|
2018
|
157 |
C |
p. 235-243
|
article
|
| 21 |
Preface: Why a Special Issue on cannabinoid research in Spain?
|
Fernández-Ruiz, Javier
|
|
2018
|
157 |
C |
p. 1-7
|
article
|
| 22 |
Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer’s disease
|
Aparicio, Noelia
|
|
2018
|
157 |
C |
p. 202-209
|
article
|
| 23 |
Role of the endocannabinoid system in drug addiction
|
Manzanares, Jorge
|
|
2018
|
157 |
C |
p. 108-121
|
article
|
| 24 |
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders
|
Mato, Susana
|
|
2018
|
157 |
C |
p. 258-265
|
article
|
| 25 |
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
|
López-Valero, Israel
|
|
2018
|
157 |
C |
p. 266-274
|
article
|
| 26 |
Δ9-tetrahydrocannabinol modulates the proteasome system in the brain
|
Salgado-Mendialdúa, V.
|
|
2018
|
157 |
C |
p. 159-168
|
article
|
| 27 |
The endocannabinoid 2-arachidonoylglycerol regulates oligodendrocyte progenitor cell migration
|
Sanchez-Rodriguez, Maria A.
|
|
2018
|
157 |
C |
p. 180-188
|
article
|
| 28 |
The endocannabinoid system in mental disorders: Evidence from human brain studies
|
Ibarra-Lecue, Inés
|
|
2018
|
157 |
C |
p. 97-107
|
article
|
| 29 |
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders
|
Río, Carmen del
|
|
2018
|
157 |
C |
p. 122-133
|
article
|
| 30 |
When orexins meet cannabinoids: Bidirectional functional interactions
|
Berrendero, Fernando
|
|
2018
|
157 |
C |
p. 43-50
|
article
|
Journal description